I will keep on following the news to see if I can join some kind of class action (although I am in Europe).
as I wrote on this board the day before AdComm, even for me that I am surely not used to read clinical trial analysis or other drug related stuff, it was clear that IPCI was far away from getting an approval.
Now I wonder: can we consider Odidiot just an idiot ?
surely not; he is a con man, who likely understood some years ago which was the way to raise money and "survive" (with very good salaries for himself and family & friends) without having a remote possibility of getting a revenue generating product on the market.
Look at the shelved ANDAs, at the Regabatin stall, at the several CRLs he has been receiving during all these years (= incompetence).
He knew he was going to fail (otherwise you don't file incomplete studies and get multiple CRLs on almost all your applications).
He is a f...g liar, sleeping with the devil
Market Data 
Markets 
AI
